Primary |
Depression |
34.5% |
Drug Use For Unknown Indication |
19.8% |
Product Used For Unknown Indication |
17.1% |
Anxiety |
8.6% |
Panic Disorder |
2.7% |
Major Depression |
2.5% |
Obsessive-compulsive Disorder |
2.3% |
Hypertension |
1.6% |
Insomnia |
1.3% |
Schizophrenia |
1.3% |
Anxiety Disorder |
1.0% |
Panic Attack |
1.0% |
Bipolar Disorder |
1.0% |
Pain |
0.9% |
Post-traumatic Stress Disorder |
0.9% |
Headache |
0.8% |
Hypothyroidism |
0.7% |
Stress |
0.7% |
Epilepsy |
0.7% |
Mental Disorder |
0.7% |
|
Withdrawal Syndrome |
18.5% |
Drug Ineffective |
13.5% |
Tremor |
9.1% |
Suicidal Ideation |
8.7% |
Vomiting |
6.9% |
Weight Increased |
5.0% |
Serotonin Syndrome |
4.8% |
Ventricular Septal Defect |
4.1% |
Somnolence |
4.0% |
Suicide Attempt |
3.4% |
Vertigo |
3.1% |
Nausea |
3.1% |
Weight Decreased |
2.5% |
Drug Withdrawal Syndrome |
2.2% |
Tearfulness |
2.1% |
Drug Exposure During Pregnancy |
2.0% |
Maternal Drugs Affecting Foetus |
1.9% |
Paraesthesia |
1.8% |
Panic Attack |
1.7% |
Completed Suicide |
1.6% |
|
Secondary |
Depression |
28.1% |
Drug Use For Unknown Indication |
25.9% |
Product Used For Unknown Indication |
16.9% |
Anxiety |
9.7% |
Major Depression |
2.2% |
Bipolar Disorder |
1.7% |
Pain |
1.6% |
Hypertension |
1.5% |
Insomnia |
1.5% |
Schizophrenia |
1.4% |
Panic Disorder |
1.3% |
Panic Attack |
1.3% |
Sedation |
1.0% |
Analgesic Therapy |
1.0% |
Psychotic Disorder |
1.0% |
Epilepsy |
1.0% |
Suicide Attempt |
0.8% |
Obsessive-compulsive Disorder |
0.8% |
Pregnancy |
0.8% |
Ill-defined Disorder |
0.7% |
|
Ventricular Septal Defect |
19.4% |
Withdrawal Syndrome |
8.0% |
Suicide Attempt |
6.9% |
Drug Ineffective |
6.6% |
Completed Suicide |
5.4% |
Weight Increased |
5.4% |
Drug Exposure During Pregnancy |
4.7% |
Tremor |
4.6% |
Suicidal Ideation |
4.0% |
Serotonin Syndrome |
3.8% |
Somnolence |
3.8% |
Multiple Congenital Abnormalities |
3.7% |
Wheezing |
3.3% |
Pulmonary Valve Stenosis |
3.2% |
Vomiting |
3.2% |
Respiratory Arrest |
3.0% |
Vision Blurred |
2.8% |
Speech Disorder Developmental |
2.7% |
Death |
2.6% |
Premature Baby |
2.6% |
|
Concomitant |
Drug Use For Unknown Indication |
22.9% |
Product Used For Unknown Indication |
17.7% |
Depression |
12.6% |
Hypertension |
6.6% |
Pain |
5.8% |
Anxiety |
5.6% |
Schizophrenia |
3.6% |
Rheumatoid Arthritis |
3.4% |
Multiple Myeloma |
3.3% |
Insomnia |
2.5% |
Diabetes Mellitus |
2.0% |
Multiple Sclerosis |
2.0% |
Gastrooesophageal Reflux Disease |
1.8% |
Prophylaxis |
1.7% |
Hiv Infection |
1.6% |
Bipolar Disorder |
1.6% |
Crohn's Disease |
1.5% |
Hepatitis C |
1.3% |
Blood Cholesterol Increased |
1.2% |
Osteoporosis |
1.2% |
|
Vomiting |
11.3% |
Weight Increased |
10.5% |
Weight Decreased |
6.5% |
Tremor |
5.5% |
Type 2 Diabetes Mellitus |
5.4% |
White Blood Cell Count Increased |
5.1% |
Nausea |
4.9% |
Pyrexia |
4.8% |
Pain |
4.4% |
Urinary Tract Infection |
4.4% |
Death |
4.2% |
Wound Drainage |
4.1% |
Rash |
4.0% |
Pulmonary Embolism |
3.9% |
Pruritus |
3.7% |
Syncope |
3.7% |
Somnolence |
3.5% |
Suicide Attempt |
3.5% |
Diarrhoea |
3.3% |
Dyspnoea |
3.3% |
|
Interacting |
Product Used For Unknown Indication |
23.5% |
Depression |
14.9% |
Sedation |
8.3% |
Neck Pain |
6.6% |
Drug Use For Unknown Indication |
5.5% |
Analgesic Therapy |
5.3% |
Post-traumatic Stress Disorder |
4.9% |
Extrapyramidal Disorder |
4.1% |
Muscle Spasms |
4.1% |
Psychotic Disorder |
4.1% |
Anxiety |
3.6% |
Dyspepsia |
2.1% |
Insomnia |
2.1% |
Anaesthesia |
1.9% |
Irritability |
1.9% |
Hiv Infection |
1.7% |
Hypertension |
1.5% |
Neuralgia |
1.5% |
Induction Of Anaesthesia |
1.3% |
Epilepsy |
1.1% |
|
Drug Interaction |
15.4% |
Muscle Rigidity |
12.8% |
Asthenia |
10.3% |
Serotonin Syndrome |
6.4% |
Abnormal Weight Gain |
5.1% |
Dizziness |
5.1% |
Tremor |
5.1% |
Urinary Retention |
5.1% |
Vomiting |
5.1% |
Wrong Drug Administered |
5.1% |
Epilepsy |
3.8% |
Viith Nerve Paralysis |
3.8% |
Weight Increased |
3.8% |
Sinus Bradycardia |
2.6% |
Urticaria |
2.6% |
Visual Impairment |
2.6% |
Balance Disorder |
1.3% |
Bradykinesia |
1.3% |
Decreased Appetite |
1.3% |
Drug Abuse |
1.3% |
|